Table 3.

Meta-regression analyses of mortality on predictors

Covariate	Coefficient	Standard error	95% lower limit	95% upper limit	Z value	Two-sided P value
Study size	0.0001	0.0002	−0.0003	0.0006	0.59	0.56
Age	0.0046	0.013	−0.021	0.031	0.35	0.73
Male, %	−0.005	0.0085	−0.022	0.012	−0.58	0.56
Diabetes, %	−0.0048	0.012	−0.028	0.018	−0.42	0.68
Hypertension, %	0.002	0.0073	−0.012	0.016	0.27	0.78
CKD, %	−0.011	0.014	−0.039	0.018	−0.74	0.46
HF, %	−0.0007	0.0093	−0.019	0.018	−0.07	0.94
CAD, %	−0.014	0.0039	−0.021	−0.006	−3.6	0.0004
Afib, %	0.011	0.021	−0.030	0.052	0.51	0.61
LVEF, %	0.011	0.0092	−0.0070	0.029	1.20	0.23
ACEi/ARB, %	0.0020	0.0076	−0.013	0.017	0.26	0.79
BB, %	−0.016	0.0052	−0.026	−0.0056	−3.05	0.0023
Diuretics, %	−0.008	0.0046	−0.0098	0.0082	−0.18	0.86
Cr, mg/dl	−0.18	0.64	−1.44	1.08	−0.28	0.78
BUN, mg/dl	−0.079	0.0057	−0.0033	0.019	1.39	0.17
eGFR, ml/min per 1.73 m2	−0.024	0.018	−0.058	0.011	−1.33	0.18
Hgb, g/dl	0.048	0.24	−0.42	0.51	0.2	0.84
Proportion of WRF, %	0.011	0.0064	−0.0020	0.023	1.65	0.099
Achievement of decongestion, %	−0.030	0.0051	−0.013	0.0069	−0.59	0.55

ACEi, angiotensin-converting enzyme inhibitor; Afib, atrial fibrillation; ARB, angiotensin II receptor blocker; BB, beta blocker; BUN, blood urea nitrogen; CAD, coronary artery disease; CKD, chronic kidney disease; Cr, creatinine; eGFR, estimated glomerular filtration rate; HF, heart failure; Hgb, hemoglobin; LVEF, left ventricular ejection fraction; WRF, worsening renal function.